Access cutting-edge metabolic dysfunction-associated steatohepatitis (mash) treatment through this phase 2 clinical trial at a research site in Austin. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Austin location
Preparing your pre-screening questions…
Access metabolic dysfunction-associated steatohepatitis (mash) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related metabolic dysfunction-associated steatohepatitis (mash) treatment provided free
Check if you qualify for this metabolic dysfunction-associated steatohepatitis (mash) clinical trial in Austin, TX
No-Cost Study Care
Local to Austin
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease called MASH. In this study, researchers are looking at the effect of ALN-CIDEB on reducing liver fat, liver injury, and liver scarring. The study will compare ALN-CIDEB with placebo to understand how well ALN-CIDEB works to lower the amount of fat in the liver. The study is looking at: * What side effects ALN-CIDEB might cause * How well ALN-CIDEB works to change liver fat, liver injury, and liver scarring * How the body and the liver change after having ALN-CIDEB, which can help researchers understand why ALN-CIDEB works better for some people than others
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT07631637) has an active research site in Austin, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for metabolic dysfunction-associated steatohepatitis (mash) treatment options in Austin, TX, this clinical trial (NCT07631637) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Austin research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced metabolic dysfunction-associated steatohepatitis (mash) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all metabolic dysfunction-associated steatohepatitis (mash) clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Austin — not just this study.
Browse Essential Tremor Trials in Austin →